Literature DB >> 2319270

Polyradiculoneuritis following botulinum toxin therapy.

B A Haug1, D Dressler, H W Prange.   

Abstract

The development of Guillain-Barré syndrome is reported in a patient, who had previously received botulinum toxin type A injections into both orbicularis oculi muscles to treat idiopathic blepharospasm. The possibility of a causal relationship is discussed with consideration of the literature on adverse effects of vaccinations and of Clostridium botulinum and its toxin.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2319270     DOI: 10.1007/bf00319673

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  16 in total

1.  The causes of the syndromes of Landry (1859) and of Guillain, Barré and Strohl (1916).

Authors:  E C Alvord; U Jahnke; E H Fischer
Journal:  Rev Neurol (Paris)       Date:  1987       Impact factor: 2.607

2.  [Polyradiculitis associated with vaccination against measles, parotitis and rubella].

Authors: 
Journal:  Lakartidningen       Date:  1984-04-18

3.  Syndrome of botulism in infancy: clinical and electrophysiologic study.

Authors:  J Pickett; B Berg; E Chaplin; M A Brunstetter-Shafer
Journal:  N Engl J Med       Date:  1976-09-30       Impact factor: 91.245

4.  An epidemiologic and clinical evaluation of Guillain-Barré syndrome reported in association with the administration of swine influenza vaccines.

Authors:  A D Langmuir; D J Bregman; L T Kurland; N Nathanson; M Victor
Journal:  Am J Epidemiol       Date:  1984-06       Impact factor: 4.897

5.  Type C botulism in American Foxhounds.

Authors:  J A Barsanti; M Walser; C L Hatheway; J M Bowen; W Crowell
Journal:  J Am Vet Med Assoc       Date:  1978-04-01       Impact factor: 1.936

6.  Treatment of blepharospasm with medication, surgery and type A botulinum toxin.

Authors:  B Arthurs; M Flanders; F Codère; S Gauthier; S Dresner; L Stone
Journal:  Can J Ophthalmol       Date:  1987-02       Impact factor: 1.882

7.  Intestinal toxicoinfection by Clostridium botulinum type F in an adult. Case associated with Guillain-Barré syndrome.

Authors:  W F Sonnabend; O A Sonnabend; P Gründler; E Ketz
Journal:  Lancet       Date:  1987-02-14       Impact factor: 79.321

8.  Risk factors for Guillain-Barré syndrome.

Authors:  R A Kaslow; J Z Sullivan-Bolyai; R C Holman; B Hafkin; R C Dicker; L B Schonberger
Journal:  Neurology       Date:  1987-04       Impact factor: 9.910

9.  Immunologic studies of rabies vaccination-induced Guillain-Barré syndrome.

Authors:  T Hemachudha; D E Griffin; W W Chen; R T Johnson
Journal:  Neurology       Date:  1988-03       Impact factor: 9.910

10.  Infant botulism. Identification of Clostridium botulinum and its toxins in faeces.

Authors:  T F Midura; S S Arnon
Journal:  Lancet       Date:  1976-10-30       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.